Features
Transparency is becoming important across a whole range of industries but, for the pharmaceutical industry, it can mean life or death. Ben...
Matt Fellows investigates how the first-ever CAR-T therapy approvals in the past months could mean the field of cancer treatment is changed...
For every completed survey, £5 will be donated to charity. We invite you to participate in this short industry-wide survey which seeks to...
After the health service struggled through the same period last year, Amber Jabbal, Head of Policy at NHS Providers sets the record straight on...
Ben Hargreaves examines the emerging practical and technological solutions that are aiming to improve patients’ access to medicines in a...
Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most important medical...
In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed its Orange Book-listed US patents covering its...
Are our pharmacovigilance measures as effective as we think? And why is it important to answer that question, especially now? Matt Fellows...
Dr Richard Hatchett, CEO of the Coalition for Epidemic Preparedness, details the lessons learned from the Ebola outbreak and the urgent need to...
Dr Áine McCarthy, Senior Science Information Officer at Cancer Research UK, discusses the latest efforts to further understand the immunotherapies...
